Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Colorectal Cancer Rates Decline; Screening Key to Further Reduction, CDC Says

A new CDC report indicates that rates of colorectal cancer diagnoses and deaths have decreased in the United States. Public health officials attribute the progress to increased screening efforts.

06/12/2026 · Georgia edition

Advertisement

Advertisement

Colorectal cancer, currently the second leading cause of cancer deaths in the United States, could be further reduced through broader screening programs, according to the Centers for Disease Control and Prevention. A recent Vital Signs report from the CDC highlights a decline in both the incidence and mortality rates associated with the disease.

The report emphasizes the crucial role of screening in early detection and prevention. Increased awareness and accessibility of screening methods such as colonoscopies and stool tests enable healthcare providers to identify and remove precancerous polyps before they develop into cancer. This proactive approach contributes significantly to improved patient outcomes.

Experts recommend that adults begin regular colorectal cancer screening at age 45, or earlier for individuals with a family history or other risk factors. The CDC encourages individuals to consult with their healthcare providers to determine the most appropriate screening schedule.

While the decline in colorectal cancer rates is encouraging, health officials stress the importance of continued efforts to promote screening and address disparities in access to care. By prioritizing prevention and early detection, public health initiatives aim to further reduce the burden of this disease.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102445 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Georgia

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Georgia

health

Florida Reports Largest Continental U.S. Dengue Outbreak in Decades

Florida has recorded its most significant dengue outbreak in decades across the continental United States. Health experts attribute the rise in cases to ongoing mosquito activity and evolving climate patterns. They anticipate a potential increase in localized outbreaks.

Read Story →
health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
health

UK Study Investigates Personalized Pain Management for Endometriosis

A new UK study will explore whether individualized pain management plans can improve quality of life for women with endometriosis. The research, backed by £2.3 million in funding, involves multiple institutions across the country.

Read Story →
Scroll for more stories